Weitere Therapieoption bei HCV-Genotyp-1/-3
Crossref DOI link: https://doi.org/10.1007/s15036-018-0384-4
Published Online: 2018-06-14
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Käser, Rafael
Thimme, Robert
Text and Data Mining valid from 2018-06-01
Article History
First Online: 14 June 2018